Biohal‘s (PONX) mission is to create a blockchain-based platform that makes preventive medicine universally available. Biohal has partnered with liquid biopsy researcher, Proteo, which accurately tests for life-threatening illnesses in minimally invasive ways. The Biohal platform, which uses AI and Dapp, will also allow for the safe, fair and transparent usage of critical medical data.
The Proteo liquid biopsy test is already available in a test center in Japan.
For more information on Biohal’s upcoming ICO and additional news, download the company’s white paper here.